These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 22859407
21. The α₁-, but not α₂-, adrenoceptor in the nucleus accumbens plays an inhibitory role upon the accumbal noradrenaline and dopamine efflux of freely moving rats. Saigusa T, Aono Y, Uchida T, Takada K, Verheij MM, Koshikawa N, Cools AR. Eur J Pharmacol; 2012 Aug 05; 688(1-3):35-41. PubMed ID: 22617026 [Abstract] [Full Text] [Related]
22. Pharmacological evidence that spinal α(2C)- and, to a lesser extent, α(2A)-adrenoceptors inhibit capsaicin-induced vasodilatation in the canine external carotid circulation. Villalón CM, Galicia-Carreón J, González-Hernández A, Marichal-Cancino BA, Manrique-Maldonado G, Centurión D. Eur J Pharmacol; 2012 May 15; 683(1-3):204-10. PubMed ID: 22445525 [Abstract] [Full Text] [Related]
23. Interaction between alpha(1)- and alpha(2)-adrenoreceptors contributes to enhanced constrictor effects of norepinephrine in mesenteric veins compared to arteries. Sporkova A, Perez-Rivera A, Galligan JJ. Eur J Pharmacol; 2010 Sep 25; 643(2-3):239-46. PubMed ID: 20599923 [Abstract] [Full Text] [Related]
24. Increases in transepithelial vectorial Na+ transport facilitates Na+-dependent L-DOPA transport in renal OK cells. Silva E, Gomes P, Soares-da-Silva P. Life Sci; 2006 Jul 17; 79(8):723-9. PubMed ID: 16600308 [Abstract] [Full Text] [Related]
25. Alpha 2-adrenoceptors in the enteric nervous system: a study in alpha 2A-adrenoceptor-deficient mice. Scheibner J, Trendelenburg AU, Hein L, Starke K, Blandizzi C. Br J Pharmacol; 2002 Feb 17; 135(3):697-704. PubMed ID: 11834617 [Abstract] [Full Text] [Related]
26. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice. Savontaus E, Fagerholm V, Rahkonen O, Scheinin M. Eur J Pharmacol; 2008 Jan 14; 578(2-3):359-64. PubMed ID: 17964569 [Abstract] [Full Text] [Related]
28. The dopamine precursor L-dihydroxyphenylalanine is transported by the amino acid transporters rBAT and LAT2 in renal cortex. Quiñones H, Collazo R, Moe OW. Am J Physiol Renal Physiol; 2004 Jul 14; 287(1):F74-80. PubMed ID: 15180924 [Abstract] [Full Text] [Related]
29. Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the α2-adrenoceptor subtypes. Cobos-Puc L, Aguayo-Morales H, Ventura-Sobrevilla J, Luque-Contreras D, Chin-Chan M. Eur J Pharmacol; 2017 Jun 15; 805():75-83. PubMed ID: 28315344 [Abstract] [Full Text] [Related]
30. Na+-independent transporters, LAT-2 and b0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines. Gomes P, Soares-da-Silva P. J Membr Biol; 2002 Mar 15; 186(2):63-80. PubMed ID: 11944084 [Abstract] [Full Text] [Related]
31. Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na(+)-K(+)-ATPase activity. Gomes P, Soares-da-Silva P. Am J Physiol Renal Physiol; 2002 Jun 15; 282(6):F1084-96. PubMed ID: 11997325 [Abstract] [Full Text] [Related]
33. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites. Alachkar A, Brotchie JM, Jones OT. Neurosci Res; 2010 Sep 01; 68(1):44-50. PubMed ID: 20542064 [Abstract] [Full Text] [Related]
35. The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats. Buck K, Voehringer P, Ferger B. J Neurochem; 2010 Jan 01; 112(2):444-52. PubMed ID: 19895663 [Abstract] [Full Text] [Related]
36. In vivo evaluation of limiting brain penetration of probes for α(2C)-adrenoceptor using small-animal positron emission tomography. Kawamura K, Akiyama M, Yui J, Yamasaki T, Hatori A, Kumata K, Wakizaka H, Takei M, Nengaki N, Yanamoto K, Fukumura T, Zhang MR. ACS Chem Neurosci; 2010 Jul 21; 1(7):520-8. PubMed ID: 22778842 [Abstract] [Full Text] [Related]
38. Inhibition of α2C-adrenoceptors ameliorates cisplatin-induced acute renal failure in rats. Tsutsui H, Shimokawa T, Miura T, Takama M, Nishinaka T, Terada T, Yamagata M, Yukimura T. Eur J Pharmacol; 2018 Nov 05; 838():113-119. PubMed ID: 30201375 [Abstract] [Full Text] [Related]
39. Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes. Amphoux A, Millan MJ, Cordi A, Bönisch H, Vialou V, Mannoury la Cour C, Dupuis DS, Giros B, Gautron S. Eur J Pharmacol; 2010 May 25; 634(1-3):1-9. PubMed ID: 20170649 [Abstract] [Full Text] [Related]
40. Pharmacological identification of the α₂-adrenoceptor subtypes mediating the vasopressor responses to B-HT 933 in pithed rats. Villamil-Hernández MT, Alcántara-Vázquez O, Sánchez-López A, Manrique-Maldonado G, Villalón CM, Centurión D. Eur J Pharmacol; 2012 Sep 15; 691(1-3):118-24. PubMed ID: 22713550 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]